PortfoliosLab logoPortfoliosLab logo
ATYR vs. AVGO
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

ATYR vs. AVGO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in aTyr Pharma, Inc. (ATYR) and Broadcom Inc. (AVGO). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

ATYR vs. AVGO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ATYR
aTyr Pharma, Inc.
-0.40%-78.37%156.74%-35.62%-70.68%92.53%-6.95%-39.91%-85.84%62.79%
AVGO
Broadcom Inc.
-10.38%50.63%110.49%104.18%-13.27%56.48%44.88%29.05%2.18%48.19%

Fundamentals

EPS

ATYR:

-$0.80

AVGO:

$5.13

PS Ratio

ATYR:

384.40

AVGO:

22.06

Total Revenue (TTM)

ATYR:

$190.00K

AVGO:

$68.28B

Gross Profit (TTM)

ATYR:

-$34.17M

AVGO:

$46.31B

EBITDA (TTM)

ATYR:

-$76.54M

AVGO:

$36.65B

Returns By Period

In the year-to-date period, ATYR achieves a -0.40% return, which is significantly higher than AVGO's -10.38% return. Over the past 10 years, ATYR has underperformed AVGO with an annualized return of -34.46%, while AVGO has yielded a comparatively higher 38.12% annualized return.


ATYR

1D
6.72%
1M
-18.73%
YTD
-0.40%
6M
8.12%
1Y
-74.17%
3Y*
-28.12%
5Y*
-29.78%
10Y*
-34.46%

AVGO

1D
5.49%
1M
-2.94%
YTD
-10.38%
6M
-5.81%
1Y
86.36%
3Y*
71.23%
5Y*
48.36%
10Y*
38.12%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ATYR vs. AVGO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ATYR
ATYR Risk / Return Rank: 2121
Overall Rank
ATYR Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
ATYR Sortino Ratio Rank: 2929
Sortino Ratio Rank
ATYR Omega Ratio Rank: 2929
Omega Ratio Rank
ATYR Calmar Ratio Rank: 1111
Calmar Ratio Rank
ATYR Martin Ratio Rank: 2020
Martin Ratio Rank

AVGO
AVGO Risk / Return Rank: 8686
Overall Rank
AVGO Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
AVGO Sortino Ratio Rank: 8787
Sortino Ratio Rank
AVGO Omega Ratio Rank: 8585
Omega Ratio Rank
AVGO Calmar Ratio Rank: 8686
Calmar Ratio Rank
AVGO Martin Ratio Rank: 8484
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ATYR vs. AVGO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for aTyr Pharma, Inc. (ATYR) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ATYRAVGODifference

Sharpe ratio

Return per unit of total volatility

-0.61

1.80

-2.41

Sortino ratio

Return per unit of downside risk

-0.03

2.52

-2.55

Omega ratio

Gain probability vs. loss probability

1.00

1.33

-0.33

Calmar ratio

Return relative to maximum drawdown

-0.83

2.95

-3.78

Martin ratio

Return relative to average drawdown

-1.16

7.31

-8.46

ATYR vs. AVGO - Sharpe Ratio Comparison

The current ATYR Sharpe Ratio is -0.61, which is lower than the AVGO Sharpe Ratio of 1.80. The chart below compares the historical Sharpe Ratios of ATYR and AVGO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


ATYRAVGODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.61

1.80

-2.41

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.36

1.15

-1.51

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.40

0.98

-1.39

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.46

1.06

-1.52

Correlation

The correlation between ATYR and AVGO is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

ATYR vs. AVGO - Dividend Comparison

ATYR has not paid dividends to shareholders, while AVGO's dividend yield for the trailing twelve months is around 0.80%.


TTM20252024202320222021202020192018201720162015
ATYR
aTyr Pharma, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
AVGO
Broadcom Inc.
0.80%0.70%0.94%1.71%3.02%2.24%3.05%3.54%3.11%1.87%1.43%1.13%

Drawdowns

ATYR vs. AVGO - Drawdown Comparison

The maximum ATYR drawdown since its inception was -99.83%, which is greater than AVGO's maximum drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for ATYR and AVGO.


Loading graphics...

Drawdown Indicators


ATYRAVGODifference

Max Drawdown

Largest peak-to-trough decline

-99.83%

-48.30%

-51.53%

Max Drawdown (1Y)

Largest decline over 1 year

-90.15%

-28.67%

-61.48%

Max Drawdown (5Y)

Largest decline over 5 years

-94.78%

-41.15%

-53.63%

Max Drawdown (10Y)

Largest decline over 10 years

-99.26%

-48.30%

-50.96%

Current Drawdown

Current decline from peak

-99.80%

-24.75%

-75.05%

Average Drawdown

Average peak-to-trough decline

-93.07%

-8.00%

-85.07%

Ulcer Index

Depth and duration of drawdowns from previous peaks

64.91%

11.56%

+53.35%

Volatility

ATYR vs. AVGO - Volatility Comparison

aTyr Pharma, Inc. (ATYR) has a higher volatility of 21.76% compared to Broadcom Inc. (AVGO) at 12.64%. This indicates that ATYR's price experiences larger fluctuations and is considered to be riskier than AVGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


ATYRAVGODifference

Volatility (1M)

Calculated over the trailing 1-month period

21.76%

12.64%

+9.12%

Volatility (6M)

Calculated over the trailing 6-month period

61.00%

32.48%

+28.52%

Volatility (1Y)

Calculated over the trailing 1-year period

121.55%

48.26%

+73.29%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

83.77%

42.34%

+41.43%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

85.40%

38.91%

+46.49%

Financials

ATYR vs. AVGO - Financials Comparison

This section allows you to compare key financial metrics between aTyr Pharma, Inc. and Broadcom Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
190.00K
19.31B
(ATYR) Total Revenue
(AVGO) Total Revenue
Values in USD except per share items